Verena Angerer

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Venues

Drug testing and analysis

Clinical toxicology (Philadelphia, Pa.)

Kantonsspital St. Gallen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kantonsspital St. Gallen Dec 01 2018

Switzerland

Chemietechnologin :: Institute of Forensic Medicine

Universitätsklinikum Freiburg Nov 01 2012 - Nov 30 2018

Germany

PhD student :: Institute of Forensic Medicine

Publications

Verena Angerer, Yasmin Schmid, Florian Franz, Heike Gnann, Jan Manuel Speer, Anke Gnann, Stephan Helmecke, Armin Buchwald, Simon D Brandt, Torsten Passie, Matthias E Liechti, Volker Auwärter
Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study. Drug testing and analysis (2023)
Michaela J Sommer, Sebastian Halter, Verena Angerer, Volker Auwärter, Florian Eyer, Gesine Liebetrau, Martin Ebbecke, Maren Hermanns-Clausen
Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids. Clinical toxicology (Philadelphia, Pa.) 60 (10) (2022)
Christina Grumann, Laura M Huppertz, Philippe Bisel, Verena Angerer, Volker Auwärter
Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM). Drug testing and analysis 11 (7) (2019)
Bjoern Moosmann, Philippe Bisel, Folker Westphal, Maurice Wilde, Jürgen Kempf, Verena Angerer, Volker Auwärter
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864). Drug testing and analysis 11 (3) (2019)
Sebastian Halter, Verena Angerer, Jörg Röhrich, Olwen Groth, Gabriele Roider, Maren Hermanns-Clausen, Volker Auwärter
Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market? Drug testing and analysis 11 (2) (2018)
Maren Hermanns-Clausen, Dieter Müller, Josephine Kithinji, Verena Angerer, Florian Franz, Florian Eyer, Hartmud Neurath, Gesine Liebetrau, Volker Auwärter
Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clinical toxicology (Philadelphia, Pa.) 56 (6) (2017)
Verena Angerer, Lukas Mogler, Jan-Patrick Steitz, Philippe Bisel, Cornelius Hess, Clara T Schoeder, Christa Elisabeth Müller, Laura M Huppertz, Folker Westphal, Jan Schäper, Volker Auwärter
Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE. Drug testing and analysis 10 (3) (2017)

Verena Angerer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Verena Angerer